Insider Trading27 Sept 2026, 09:30 am
Sampre Nutritions Closes Trading Window for Q2 FY27 Results
AI Summary
Sampre Nutritions Ltd has announced the closure of its trading window for the second quarter ended September 30, 2026. This closure, effective from October 1, 2026, will last until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the period. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. All promoters, directors, designated persons, and their immediate relatives are prohibited from trading in the company's securities during this period. The date for the Board of Directors' meeting to approve these results will be communicated separately.
Key Highlights
- Trading window closed from October 1, 2026, for Q2 FY27 results.
- Applies to promoters, directors, and designated persons.
- Aims to comply with SEBI Insider Trading Regulations.
- Prohibition on trading in company securities during closure.
- Board meeting date for results declaration to be announced later.
Price Impact
More from SAMPRE